Medtronic plc (NYSE:MDT) is one of the Best Wide Moat Dividend Stocks to Invest in. The company remains a major player in the medical technology space as it focuses on medical devices. Its broad ...

The new diabetes company will be predominantly business-to-consumer, while Medtronic’s model was more business-to-business.

In a surprise move, Medtronic plans to spin off its diabetes business. This is Medtronic's smallest business, but also its fastest-growing one. The new entity could be attractive to more growth ...

IT and business leaders attending this year’s SAP Sapphire event learned of SAP’s combination of enterprise apps, context-aware data, and world-class Business AI.

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced its intent to separate its Diabetes business into a new standalone company ("New Diabetes Company"). This ...

Business Medtronic to spin off diabetes business, form new company The separation is expected to be completed in 18 months.

Medical-device maker Medtronic MDT 0.71% plans to separate its diabetes business into a stand-alone company, the company said, in a move that hives off a division that had struggled but recently ...

Medical device maker Medtronic said on Wednesday it plans to separate its diabetes business, which houses its insulin pumps and other wearable devices, into a stand-alone company and forecast 2026 ...

Medtronic said Wednesday it plans to separate its diabetes business, which generates more than $2.8 billion in annual sales, into a new publicly traded company.

The company says it plans to separate the two entities within 18 months but will still need to get the approval of the Medtronic Board of Directors.

Medtronic is targeting completion of the planned separation within 18 months, subject to customary conditions, including favorable market conditions, consultations with works councils and other ...